Estudo observacional | Envolvimento farmacêutico no cuidado de pacientes críticos pode reduzir a utilização de recursos, os eventos adversos medicamentosos e os custos médicos.

PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study – Critical Care Explorations

Comentário do autor no Twitter (fio – clique para saber mais)

PHARM-CRIT Study
👩‍🔬 215 ICU PharmDs at 85 centers
💊55,926 accepted interventions on 27,681 patients over 3,148 shifts
💵$23,404,089 cost avoidance; monetary benefit-to-cost ratio for ICU pharmacists $3.3:1 – $9.6:1@SCCM_CPP @SCCM #TwitteRx #PharmICU https://t.co/Hv4jPwU6eb

— Megan Rech, PharmD, MS (@MeganARech) December 16, 2021